2022 - Research.com Materials Science in Finland Leader Award
His primary areas of study are Drug delivery, Nanotechnology, Nanoparticle, Particle size and Drug carrier. Jouni Hirvonen combines subjects such as Biodistribution, Biocompatibility, Bioavailability, Controlled release and Drug with his study of Drug delivery. Jouni Hirvonen has researched Nanotechnology in several fields, including Cellulose, Porous silicon, Polymer and Dissolution.
His Dissolution research integrates issues from Solubility, Nuclear chemistry, Ibuprofen, Dissolution testing and Microparticle. His Nanoparticle study integrates concerns from other disciplines, such as Nanocomposite, Surface modification, Hydrophobin, Biophysics and Cytotoxicity. The concepts of his Particle size study are interwoven with issues in Aqueous solution, Organic chemistry, Silica gel, Dynamic light scattering and Crystallinity.
His primary areas of investigation include Drug delivery, Nanotechnology, Nanoparticle, Chromatography and Porous silicon. His research integrates issues of Biocompatibility, Biophysics and Drug in his study of Drug delivery. His research links Dissolution with Nanotechnology.
His studies deal with areas such as Bioavailability and Dissolution testing as well as Dissolution. His study on Nanoparticle also encompasses disciplines like
Polymer that connect with fields like Polymer chemistry,
Particle size which connect with Solubility. His research on Chromatography also deals with topics like
Pharmacology and Membrane most often made with reference to Iontophoresis,
Transdermal which connect with Penetration.
The scientist’s investigation covers issues in Drug delivery, Nanotechnology, Nanoparticle, Cancer research and Biophysics. His Drug delivery study incorporates themes from Biomedical engineering, Cell membrane and Drug. Nanotechnology connects with themes related to Nano- in his study.
Jouni Hirvonen has included themes like Biocompatibility, Porous silicon and Surface modification in his Nanoparticle study. His biological study spans a wide range of topics, including Wound healing and Internalization. He has researched Nanocrystal in several fields, including Particle size, Polymer and Dissolution.
Jouni Hirvonen spends much of his time researching Drug delivery, Nanotechnology, Nanoparticle, Microfluidics and Surface modification. His Drug delivery study integrates concerns from other disciplines, such as Dextran, Porous silicon, Biomedical engineering and Cancer immunotherapy. His Nanotechnology research is multidisciplinary, incorporating elements of Drug, Nano- and Polymer.
He combines subjects such as Biophysics, Nanocomposite, Cytotoxicity and Biosensor with his study of Nanoparticle. His study focuses on the intersection of Surface modification and fields such as Organic chemistry with connections in the field of Nuclear chemistry, Absorption, Bioavailability and Curcumin. His work carried out in the field of Nanocrystal brings together such families of science as Solubility and Dissolution.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cytotoxicity of thermosensitive polymers poly(N-isopropylacrylamide), poly(N-vinylcaprolactam) and amphiphilically modified poly(N-vinylcaprolactam).
Henna Vihola;Antti Laukkanen;Lauri Valtola;Heikki Tenhu.
Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs.
J. Salonen;L. Laitinen;A.M. Kaukonen;J. Tuura.
Journal of Controlled Release (2005)
Mesoporous silicon in drug delivery applications.
Jarno Salonen;Ann M. Kaukonen;Jouni Hirvonen;Vesa-Pekka Lehto.
Journal of Pharmaceutical Sciences (2008)
Biocompatibility of Thermally Hydrocarbonized Porous Silicon Nanoparticles and their Biodistribution in Rats
Luis M. Bimbo;Mirkka Sarparanta;Hélder A. Santos;Anu J. Airaksinen.
ACS Nano (2010)
Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods
Leena Peltonen;Jouni Hirvonen.
Journal of Pharmacy and Pharmacology (2010)
Properties and chemical modifications of lignin: Towards lignin-based nanomaterials for biomedical applications
Patrícia Figueiredo;Kalle Lintinen;Jouni T. Hirvonen;Mauri A. Kostiainen.
Progress in Materials Science (2018)
Mesoporous silica material TUD-1 as a drug delivery system.
T. Heikkilä;J. Salonen;J. Tuura;M.S. Hamdy.
International Journal of Pharmaceutics (2007)
Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than the other UGTs and was purified as an active dimeric enzyme
Mika Kurkela;J. Arturo Garcı́a-Horsman;Leena Luukkanen;Saila Mörsky.
Journal of Biological Chemistry (2003)
Nanosuspensions of poorly soluble drugs: Preparation and development by wet milling
Peng Liu;Xinyu Rong;Xinyu Rong;Johanna Laru;Bert van Veen.
International Journal of Pharmaceutics (2011)
Drug release from nanoparticles embedded in four different nanofibrillar cellulose aerogels
Hanna Valo;Suvi Arola;Päivi Laaksonen;Mika Torkkeli.
European Journal of Pharmaceutical Sciences (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: